{
  "id": "bced730532793040",
  "title": "March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB - 105 CD5 CAR - T Cell Therapy at ASH 2025 Annual Meeting",
  "description": "20251208T160000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/08/tmt-newswire/globenewswire/march-biosciences-presents-positive-interim-clinical-data-from-phase-2-trial-of-mb-105-cd5-car-t-cell-therapy-at-ash-2025-annual-meeting/2239197",
  "published_at": "20251208T160000Z",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/08/tmt-newswire/globenewswire/march-biosciences-presents-positive-interim-clinical-data-from-phase-2-trial-of-mb-105-cd5-car-t-cell-therapy-at-ash-2025-annual-meeting/2239197",
    "url_mobile": "https://www.manilatimes.net/2025/12/08/tmt-newswire/globenewswire/march-biosciences-presents-positive-interim-clinical-data-from-phase-2-trial-of-mb-105-cd5-car-t-cell-therapy-at-ash-2025-annual-meeting/2239197/amp",
    "title": "March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB - 105 CD5 CAR - T Cell Therapy at ASH 2025 Annual Meeting",
    "seendate": "20251208T160000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/08/859055.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}